Key result
COVID-19 delays return to play beyond 28 days in ~27% of elite athletes, linked to chest pain.
Why the study?
The COVID-19 pandemic required new practices in sports medicine patient care to ensure safety and access while managing infection risks.
The COVID-19 pandemic necessitated new practices in sports medicine, including telehealth and symptom screening, with chest pain identified as a key predictor of prolonged time loss in athletes.
Chest pain may flag athletes needing extended monitoring post-COVID; leaves open prospective validation before guiding return-to-play protocols.
The COVID-19 pandemic has necessitated new practices in sports medicine patient care. Telehealth has been validated as a reliable tool for consultations and physical examinations and increases access to care in a cost-efficient manner. Social distancing and avoiding team members who have tested positive are the most effective ways to reduce spread. For screening, daily self-reported symptom checklists and fever monitoring help identify potentially infected athletes who should be instructed to isolate and seek care. Polymerase chain-reaction (PCR) testing for the virus via nasopharyngeal swab is not recommended for screening and should be reserved for symptomatic individuals with fever, cough, or shortness of breath. Face masks and personal protective equipment (PPE) may be beneficial in high-risk settings, but there is little evidence to support use in athletic populations. Median return to play after COVID-19 in elite athletes has been reported as 18 days (range: 12 to 30), with 27% not fully available at 28 days. Chest pain at diagnosis was the only symptom associated with time loss longer than 28 days. Finally, canceled competitions or time loss results in grief, stress, and frustration for athletes, as well as loss of a social support network and routine training regimens. Mental health support services may be indicated.
No takes yet. Share an insight, caveat, or question.
Peebles et al. (2022) conducted a review in COVID-19. COVID-19 was evaluated on Return to play. Median return to play after COVID-19 in elite athletes was 18 days, with 27% not fully available at 28 days, and chest pain was associated with time loss longer than 28 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: